<DOC>
	<DOCNO>NCT01637103</DOCNO>
	<brief_summary>Depressive symptom highly frequent among cancer patient . These symptom significantly impair quality life ( e.g. , hopelessness , great risk suicidal behaviour ) may even affect patient ' prognosis ( e.g. , decreased adherence cancer treatment ) . Cognitive therapy ( CT ) establish treatment depression general population , efficacy yet investigate non-metastatic cancer patient . Furthermore , accessibility CT limit routine cancer care many patient reluctant use pharmacological treatment , often turn alternative treatment bright light therapy ( BLT ) , empirical data efficacy need use recommend . Goal 1 : To assess post-treatment , compare waiting-list control condition , effect bright light therapy ( BLT ) cognitive therapy ( CT ) : ( 1a ) reduce depressive symptom ; ( 1b ) improve subjective objective sleep parameter , reduce fatigue anxiety increase patient ' function quality life . Goal 2 : To compare post-treatment 3- 6-month follow-up effect BLT CT : ( 2a ) reduce depressive symptom ; ( 2b ) improve subjective objective parameter sleep , reduce fatigue anxiety increase patient ' function quality life . It hypothesize , As compare control patient wait period , BLT CT group significantly great improvement symptom post-treatment . However , compare BLT patient , CT patient show great improvement symptoms post-treatment 3- 6-month follow-up . This study provide empirical data efficacy two approach treat depressive symptom cancer patient order well inform scientific community , health care provider , patient effective depression treatment implement cancer care .</brief_summary>
	<brief_title>Treatment Depressive Symptoms Breast Cancer Patients : Comparison Cognitive Therapy Bright Light Therapy</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<criteria>receive diagnosis stage IIII cancer within past 18 month ; score 7 high depression subscale Hospital Anxiety Depression Scale ( HADSD ) 84 14 high Beck Depression InventoryII ( BDIII ) ; receive bright light therapy past month previously receive cognitive therapy depression ; severe cognitive impairment ( e.g. , diagnosis Parkinson 's disease , dementia , MiniMental State Examination [ MMSE ] score &lt; 27 ) ; meet DSMIV criterion major depressive episode severe intensity , another severe psychiatric disorder ( e.g. , psychotic , bipolar , substance use disorder ) ; present suicidal ideation risk acting , attempt suicide past five year ; start new psychotropic medication modify dosage frequency use past two week ; currently take photosensitive medication ( e.g. , lithium , Ltryptophan ) ; evidence ocular pathology optometrist exam medical condition contraindicating use bright light therapy ( e.g. , severe cataract , glaucoma , diabetes ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Cancer</keyword>
	<keyword>Depression</keyword>
	<keyword>Anxiety</keyword>
	<keyword>Fatigue</keyword>
	<keyword>Sleep</keyword>
	<keyword>Quality life</keyword>
	<keyword>Cognitive therapy</keyword>
	<keyword>Bright light therapy</keyword>
</DOC>